论文部分内容阅读
目的:观察并探讨氯吡格雷和阿司匹林肠溶片在治疗急性脑梗死中的临床观察与疗效分析。方法:选取2014年12月~2015年12月来我院治疗的40例急性脑梗死患者进行回顾性分析,随机分成两组,即观察组与对照组。对照组患者采取临床常规治疗加用阿司匹林肠溶片,观察组患者采取临床常规治疗加用阿司匹林肠溶片联合氯吡格雷,观察两组患者在经过各自治疗后的临床疗效对比。结果:经比较得知,在基础治疗上采用氯吡格雷和阿司匹林肠溶片的观察组患者在临床疗效方面明显优于对照组,两组患者的临床疗效比存在显著差异(P<0.05),具有统计学意义。结论:氯吡格雷和阿司匹林肠溶片在治疗急性脑梗死的临床上疗效明确,值得加大临床的推广及应用。
Objective: To observe and investigate the clinical observation and curative effect of clopidogrel and aspirin enteric-coated tablets in the treatment of acute cerebral infarction. Methods: Forty patients with acute cerebral infarction who were treated in our hospital from December 2014 to December 2015 were retrospectively analyzed and randomly divided into two groups: the observation group and the control group. The patients in the control group were treated with aspirin enteric-coated tablets. The patients in the observation group were treated with aspirin enteric-coated tablets combined with clopidogrel. The clinical efficacy of the two groups were compared after treatment. Results: Compared with the control group, the observation group on the basis of treatment with clopidogrel and aspirin enteric-coated tablets was significantly better than the control group, the clinical efficacy of the two groups were significantly different (P <0.05) has statistical significane. Conclusion: The clinical effect of clopidogrel and aspirin enteric-coated tablets in the treatment of acute cerebral infarction is clear, it is worth to increase the clinical promotion and application.